The protein made by the DNAJB1 gene helps your cells manage proteins so they fold into the right shape and do not clump together. If the DNAJB1 gene does not work as it should, cells may cope less well with stress and damaged proteins can build up. Most inherited variants in this gene are not a common cause of disease, but DNAJB1 is important in medicine because a DNAJB1-PRKACA gene fusion, where two genes become joined, is closely linked to fibrolamellar liver cancer.
What is a gene?
Genes are stretches of DNA that give your cells instructions they can use to make molecules or regulate processes in the body. Some genes carry the information needed to produce proteins, the working parts of cells. Others mainly help direct when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
DNAJB1Gene function
What if the gene works
The DNAJB1 gene helps cells fold proteins into the right shape and limits protein clumping. It works with other protein helpers, especially during heat or other stress, to keep routine cell activity running smoothly.
Risk
What if the gene does not work
Milder to more severe variants in the DNAJB1 gene can reduce how well cells fold, stabilize, and clear proteins. This can weaken the cell’s stress response and disrupt normal protein quality control.
Treatment
What does that mean for your treatment
No DNAJB1-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the DNAJB1 gene. Separately, the DNAJB1-PRKACA fusion is being studied as a biomarker and possible treatment target in fibrolamellar liver cancer.
Conditions associated with DNAJB1
Gene function
What if the gene works
Every day, your cells make and recycle large numbers of proteins. The DNAJB1 gene helps keep that work organized by guiding proteins toward the right shape and helping cell stress responses run smoothly. Understanding what the DNAJB1 gene does in your cells helps explain how protein quality is maintained over time.
The DNAJB1 gene helps new or partly unfolded proteins reach a stable shape. It recognizes proteins that need help and brings them into the cell’s folding system.
Its protein works closely with HSP70, a protein helper that folds and stabilizes other proteins. DNAJB1 helps switch HSP70 into an active working cycle so folding can move forward.
During normal cell activity and after stress, this gene helps keep loose proteins from sticking together in clumps. That keeps the cell’s protein environment more orderly and easier to manage.
This gene also supports protein quality control by helping cells sort proteins that still need attention. Some can be refolded, while others are guided toward breakdown and recycling.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and form part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant may affect a gene’s function more strongly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How variants influence the DNAJB1 gene's function often depends on how much they alter the DNAJB1 protein's shape and stability. Some variants weaken the part that works with HSP70, a partner protein that helps manage protein folding, while more disruptive variants can shorten the protein or cause it to break down early. This creates a spectrum from milder changes with partial activity to more severe changes with little or no co chaperone activity.
How variants are linked to conditions
Variants in the DNAJB1 gene are not broadly confirmed as a cause of an inherited genetic condition. The best established DNAJB1 gene link to disease involves fibrolamellar liver cancer, where tumor cells usually carry an acquired DNAJB1::PRKACA fusion rather than an inherited DNAJB1 variant. In this setting, the finding supports the diagnosis of fibrolamellar carcinoma, but it does not mean family members carry the same change.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely present in the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the DNAJB1 gene itself. Anyone with concerns about their personal or family risk can discuss this with a doctor or genetic counselor.
Inheritance of DNAJB1 variants
DNAJB1 gene inheritance is not tied to a single, well-established inherited condition at this time. Current evidence does not support one broadly confirmed Mendelian pattern, such as autosomal dominant or autosomal recessive, for inherited DNAJB1-related disease. The DNAJB1 gene is located on chromosome 19, which is an autosome, so each person inherits one copy from each parent. Some DNAJB1 changes described in cancer are acquired during life in cells and are not passed from parent to child.
What does my DNAJB1 result mean for my family?
There is not yet a broadly confirmed inherited pattern tied to a specific health condition for DNAJB1. If you have a DNAJB1 result and want to understand what it could mean for relatives, a doctor or genetic counselor can review the exact finding and explain whether any family testing is relevant.
Genetic information
Genetic testing
How you find out about variants
Testing of the DNAJB1 gene for variants usually uses a blood or saliva sample, while tumor testing may use tissue. A lab reads the DNAJB1 gene with DNA sequencing and, when needed, checks for larger changes or a DNAJB1-PRKACA fusion, a joined gene change. Results show whether a variant or fusion was found.
When should I consider getting a genetic test?
Testing is usually considered only when doctors are checking a liver tumor for fibrolamellar cancer, because a DNAJB1 change in the tumor, often where DNAJB1 joins another gene, can help confirm the diagnosis. This is typically a tumor test, not an inherited test for a change passed down in families.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood along with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target, and this kind of variation is common.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect a person’s response to medication. It studies the relationship between genes and drugs to better understand why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works and how the body processes it. This information can help support more informed, individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the DNAJB1 gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in guiding medication choice or dosing at this time. Questions about side effects, treatment response, or other health concerns are best discussed with your doctor.
History
The DNAJB1 gene was identified as part of the human DnaJ or HSP40 family, a group named after an earlier bacterial gene that helped shape early stress response research. In recent decades, awareness of this gene’s role has grown. Early work placed the DNAJB1 gene among a larger set of genes active when cells are under strain, and that helped researchers connect older laboratory findings across species. A major turning point came in the 2010s, when scientists found a recurrent DNAJB1-PRKACA gene fusion in fibrolamellar carcinoma, a rare liver cancer. From these first observations, research expanded steadily. That discovery made the DNAJB1 gene especially important in cancer studies because it offered a clear genetic clue in a disease that had long puzzled doctors.